StockTipsArenaBeta

BUY Caplin Point Laboratories Limited — Shrikant Chouhan, Kotak Securities

BUYCaplin Point Laboratories Limited
Caplin Point Laboratories share price target & all analyst calls

byShrikant Chouhan, Kotak SecuritiesHorizon: 1–3 months24 Sept 2026via NDTV Profit

Entry₹2,974.4Inferred
Target₹3,300
Total upside +10.95%
Stop lossNot given
CMP₹2,388.71d ago
Active-19.69%+38.15%upside left 6 wk left
Follow Shrikant Chouhan for new calls(46% target hit, 37 closed calls)Get alertsWatch CAPLIPOINT for new buy/sell callsGet alertsSee 84 other Short-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 15 Nov, 3:29 am IST
3 supporting3 neutral0 opposing
Supports the BUY call (3)

MACD above its signal line — bullish momentum

Technicals · macd·14 Nov · today

Neutral / worth noting (3)

Caplin Point Laboratories Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.

NSE · Outcome of Board Meeting·12 Nov · 2d ago

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Caplin Point Laboratories

All analyst calls on Caplin Point Laboratories

More from Shrikant Chouhan, Kotak Securities

Every call and its outcome